bioAffinity Technologies Debt-to-Assets Ratio Growth & History (BIAF)

bioAffinity Technologies's debt-to-assets ratio was 0.09 for fiscal 2025.

View full bioAffinity Technologies company overview

bioAffinity Technologies annual debt-to-assets ratio history

bioAffinity Technologies annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20252025-12-310.09−0.11−53.96%
20242024-12-310.200.01+4.69%
20232023-12-310.190.17+829.16%
20222022-12-310.02−7.65−99.73%
20212021-12-317.67

bioAffinity Technologies debt-to-assets ratio trends

Between the periods ended 2021-12-31 and 2025-12-31, bioAffinity Technologies's debt-to-assets ratio decreased from 7.67 to 0.09, a change of −7.58. The latest reported quarter, Q2 2026, shows 0.18.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review bioAffinity Technologies source filings ↗

Community posts

It’s quiet here.

No posts about BIAF yet. Start the conversation.

Write the first post